Financials
- Market Capitalization 427.7 M
- Employee 23
- Founded 2014
- CEO N/A
- Website www.ovidrx.com
- Headquarter Delaware, United States
- FIGI BBG009F0TD76
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-7.09
ratio cours/chiffre d'affaires
16.57
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2954 | ENTX Entera Bio Ltd. - Ordinary Shares | 2.49 USD | -6.04% | -1.58% | -11.39% | -2.35% | 431.12 M USD | ||
| 2958 | PRTA Prothena Corporation plc - Ordinary Shares | 8.37 USD | -0.71% | +4.36% | -6.48% | -18.90% | 429.69 M USD | ||
| 2971 | DMAC DiaMedica Therapeutics Inc. - Common Stock | 7.84 USD | -4.39% | -3.57% | +20.80% | +11.36% | 422.78 M USD | ||
| 2974 | ASMB Assembly Biosciences, Inc. - Common Stock | 20.34 USD | -10.67% | -8.30% | -32.89% | -30.88% | 414.13 M USD |